Chara Biologics: Arriving At Joy
Meaning of Chara
Chara is the Greek word for Joy. It describes a feeling of inner gladness, delight or rejoicing. Chara is a deep-seated pleasure; it is a depth of assurance and confidence that ignites a cheerful heart. It does not come from favorable circumstances, but from a deep sense of wellbeing in the heart of the person who knows all is well between himself and the Lord.
Joy Kong, M.D. founded Chara Biologics after encountering significant levels of lack of integrity in the regenerative medicine industry. As a founder of the company, her goal is for Chara Biologics to serve as a force of integrity, high standard and innovation in the industry. Chara is also dedicated in providing physician education and training to help doctors practice regenerative medicine safely and effectively.
Dr. Kong is an anti-aging and regenerative medicine specialist, and the president of Thea Center for Regenerative Medicine in Los Angeles, California. She is also the founder and president of American Academy of Integrative Cell Therapy.
Dr. Kong has lectured nationally and internationally on cell therapy, exchanged ideas with top stem cell scientists from around the globe, and worked closely with various cell laboratories in this country. She is always on the search for the best regenerative medicine products on the market; and as a proponent for high quality clinical research, she co-founded a research organization along with other pioneers in the regenerative medicine field, to spearhead high quality clinical studies on various serious medical conditions using cell therapy. Chara Biologics’ mission is to be a contributing force in bringing the practice of medicine into the 21st century.
We strive to provide the highest quality regenerative medicine products in the marketplace. Our state-of-the-art laboratory is fully FDA-compliant, adheres to AATB (American Association of Tissue Banks) standards, and uses minimal manipulative proprietary technology to produce products of the highest therapeutic potential. Our products are obtained from donors using the most stringent selection criteria, to ensure patients’ safety.